Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.
Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 10, 2026, 1 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.
Webinar presenter Jeffrey Gregg, MD, University of Nevada
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
PAML, through a partnership with Verinata Health, is now offering the Verifi prenatal test for all patients within the network desiring noninvasive prenatal testing to detect Down syndrome, Edwards syndrome, Patau syndrome, and sex chromosome abnormalities, the most common genetic abnormalities tested for during pregnancy.
Clean Collect blood culture kits, available from Stone Medical, prevent contamination of blood cultures using a patented diversion method.
SciGene’s new sodium thiocyanate pretreatment reagent, a convenient 1-M liquid formulation of NaSCN for pretreating tissue samples prior to application of nucleic acid probes for cytogenetic assays, joins an expanding line of FISH slide-processing products from SciGene.
Smart Imaging Technologies’ Interactive Web Reports for its Simagis Live Digital Pathology servers make it possible for pathologists to complete and sign off digital cases, create professional, media-rich reports from digital slides, and share them instantly with clients, colleagues, or patients.
Waters Corp. has unveiled its Web-based Oasis method development tools, which are designed to help customers reduce their sample preparation method development time as part of Waters’ simple prep campaign.
Denville Scientific’s new line of microscopes includes basic and advanced models designed to provide maximum optical performance on durable and affordable platforms.
The selection includes epifluorescence and stereo-zoom models as well as models with trinocular camera and video mounts. A range of objectives are available, and all microscopes come with a five-year mechanical warranty.
The Liquidator 96 bench-scale manual pipetting solution from Mettler Toledo subsidiary Rainin Instrument provides accuracy without forcing operators to contend with electronic systems or complex computer programming.
Luminex announced it has received FDA and European clearance for a comprehensive genotyping assay, xTAG CYP2C19 kit. This new test provides a personalized approach to determining patient treatment based on certain genetic variants of the P450 2C19 gene.
The Clinical and Laboratory Standards Institute has published an updated version of “MM07-A2–Fluorescence In Situ Hybridization Methods for Clinical Laboratories; Approved Guideline–Second Edition.” This document addresses FISH methods for medical genetic determinations, identification of chromosomal abnormalities, and gene amplification.
Multisorb Technologies offers its Quality by Design (QbD)-based Calculations through Operations Program. Multisorb’s scientists use the program to determine the optimized sorbent for the application and to manage placement of that sorbent during packaging operations, when required, with the use of a sorbent-specific dispenser. The program and use of a Multisorb system provide an effective solution for ensuring chemical and physical stability for IVD devices through their desired shelf life. For complex stability requirements, optimized sorbent solutions are available with
